Impact Biomedical (IBO) Other Non Operating Income (2023 - 2024)
Impact Biomedical (IBO) posted Other Non Operating Income of $5.7 million for Q3 2024, up 10803.85% on a QoQ basis from $52000.0 in Q1 2023.
Impact Biomedical (IBO) Other Non Operating Income (2023 - 2024) Analysis & Trends
Impact Biomedical's Other Non Operating Income history runs 2 years deep, the most recent figure standing at $5.7 million for Q3 2024.
- Quarterly Other Non Operating Income changed N/A year-over-year to $5.7 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $5.7 million (changed N/A YoY) and the FY2023 annual result came in at $52000.0, down 21.21% from the prior year.
- Other Non Operating Income was $5.7 million for Q3 2024 at Impact Biomedical, up from $52000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $5.7 million in Q3 2024 and bottomed at $52000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 5.67 Mn |
| Mar 31, 2023 | 52,000.00 |